Zlatan Alagic

Zlatan Alagic

Auto-generated profile, based on publicly available information

Zlatan Alagic

Department of Diagnostic Radiology, Karolinska University hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in Journal of Medical Imaging
Verified
Journal Article
Closed access
PDF file
JSJoakim da Silva
Joakim da Silva
FGFredrik Grönberg
Fredrik Grönberg
BCBjörn Cederström
Björn Cederström
MPMats Persson
Mats Persson
MSMartin Sjölin
Martin Sjölin
MDMats Danielsson
Mats Danielsson
<!-- *** Custom HTML *** --> Photon-counting detectors are expected to bring a range of improvements to patient imaging with x-ray computed tomography (CT). One is higher spatial resolution. We demonstrate the resolution obtained using a commercial CT scanner where the original energy-integrating detector has been replaced by a single-slice, silicon-based, photon-counting detector. This prototype constitutes the first full-field-of-view silicon-based CT scanner capable of patient scanning. First, the pixel response function and focal spot profile are measured and, combining the two, the system modulation transfer function is calculated. Second, the prototype is used to scan a resolution phantom and a skull phantom. The resolution images are compared to images from a state-of-the-art CT scanner. The comparison shows that for the prototype 19 lp / cm are detectable with the same clarity as 14 lp / cm on the reference scanner at equal dose and reconstruction grid, with more line pairs visible with increasing dose and decreasing image pixel size. The high spatial resolution remains evident in the anatomy of the skull phantom and is comparable to that of other photon-counting CT prototypes present in the literature. We conclude that the deep silicon-based detector used in our study could provide improved spatial resolution in patient imaging without increasing the x-ray dose.

9 September 2019 in Skeletal Radiology
Verified
Journal Article
Open access
PDF file
ZAZlatan Alagic
Zlatan Alagic
RBRobert Bujila
Robert Bujila
AEAnders Enocson
Anders Enocson
SSSubhash Srivastava
Subhash Srivastava
SKSeppo K. Koskinen
Seppo K. Koskinen
Objective: The purpose of this study was to assess if ultra-low-dose CT is a useful clinical alternative to digital radiographs in the evaluation of acute wrist and ankle fractures. Materials and methods: An ultra-low-dose protocol was designed on a 256-slice multi-detector CT. Patients from the emergency department were evaluated prospectively. After initial digital radiographs, an ultra-low-dose CT was performed. Two readers independently analyzed the images. Also, the radiation dose, examination time, and time to preliminary report was compared between digital radiographs and CT. Results: In 207 extremities, digital radiography and ultra-low-dose CT detected 73 and 109 fractures, respectively (p < 0.001). The odds ratio for fracture detection with ultra-low-dose CT vs. digital radiography was 2.0 (95% CI, 1.4–3.0). CT detected additional fracture-related findings in 33 cases (15.9%) and confirmed or ruled out suspected fractures in 19 cases (9.2%). The mean effective dose was comparable between ultra-low-dose CT and digital radiography (0.59 ± 0.33 μSv, 95% CI 0.47–0.59 vs. 0.53 ± 0.43 μSv, 95% CI 0.54–0.64). The mean combined examination time plus time to preliminary report was shorter for ultra-low-dose CT compared to digital radiography (7.6 ± 2.5 min, 95% CI 7.1–8.1 vs. 9.8 ± 4.7 min, 95% CI 8.8–10.7) (p = 0.002). The recommended treatment changed in 34 (16.4%) extremities. Conclusions: Ultra-low-dose CT is a useful alternative to digital radiography for imaging the peripheral skeleton in the acute setting as it detects significantly more fractures and provides additional clinically important information, at a comparable radiation dose. It also provides faster combined examination and reporting times.

29 April 2021 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
KPK. Pálsdóttir
K. Pálsdóttir
SFSusanne Fridsten
Susanne Fridsten
LBL. Blomqvist
L. Blomqvist
ZAZ. Alagic
Z. Alagic
DFDaniela Fischerova
Daniela Fischerova
EEElisabeth Epstein
Elisabeth Epstein
Objective: To evaluate interobserver agreement for the assessment of local tumor extension in women with cervical cancer, among experienced and less experienced observers, using transvaginal ultrasound (TVS) and magnetic resonance imaging (MRI).Methods: The TVS observers were all gynecologists and consultant ultrasound specialists, six with and seven without previous experience in cervical cancer imaging. The MRI observers were five radiologists experienced in pelvic MRI and four less experienced radiology residents without previous experience in MRI of the pelvis. The less experienced TVS observers and all MRI observers underwent a short basic training session in the assessment of cervical tumor extension, while the experienced TVS observers received only a written directive. All observers were assigned the same images from cervical cancer patients at all stages (n = 60) and performed offline evaluation to answer the following three questions: (1) Is there a visible primary tumor? (2) Does the tumor infiltrate > ⅓ of the cervical stroma? and (3) Is there parametrial invasion? Interobserver agreement within the four groups of observers was assessed using Fleiss kappa (κ) with 95% CI.Results: Experienced and less experienced TVS observers, respectively, had moderate interobserver agreement with respect to tumor detection (κ (95% CI), 0.46 (0.40–0.53) and 0.46 (0.41–0.52)), stromal invasion > ⅓ (κ (95% CI), 0.45 (0.38–0.51) and 0.53 (0.40–0.58)) and parametrial invasion (κ (95% CI), 0.57 (0.51–0.64) and 0.44 (0.39–0.50)). Experienced MRI observers had good interobserver agreement with respect to tumor detection (κ (95% CI), 0.70 (0.62–0.78)), while less experienced MRI observers had moderate agreement (κ (95% CI), 0.51 (0.41–0.62)), and both experienced and less experienced MRI observers, respectively, had good interobserver agreement regarding stromal invasion (κ (95% CI), 0.80 (0.72–0.88) and 0.71 (0.61–0.81)) and parametrial invasion (κ (95% CI), 0.69 (0.61–0.77) and 0.71 (0.61–0.81)).Conclusions: We found interobserver agreement for the assessment of local tumor extension in patients with cervical cancer to be moderate for TVS and moderate‐to‐good for MRI. The level of interobserver agreement was associated with experience among TVS observers only for parametrial invasion. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

15 May 2019 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
ZAZlatan Alagic
Zlatan Alagic
HAHaris Alagic
Haris Alagic
RBRobert Bujila
Robert Bujila
SSSubhash Srivastava
Subhash Srivastava
SJSaif Jasim
Saif Jasim
MWMarius C Wick
Marius C Wick
Background: The use of computed tomography (CT) for image guidance during biopsies is a powerful approach. The method is, however, often associated with a significant level of radiation exposure to the patient and operator. Purpose: To investigate if a low-dose protocol for CT-guided musculoskeletal (MSK) biopsies, including a combination of different radiation dose (RD) techniques, is feasible in a clinical setting. Material and Methods: Fifty-seven patients underwent CT-guided fine-needle aspiration cytology (FNAC) utilizing the low-dose protocol (group A). A similar number of patients underwent CT-guided FNAC using the reference protocol (group B). Between-group comparisons comprised radiation dose, success rate, image quality parameters, and workflow. Results: In group A, the mean total dose-length product (DLP) was 41.2 ± 2.9 mGy*cm, which was statistically significantly lower than of group B (257.4 ± 22.0 mGy*cm), corresponding to a mean dose reduction of 84% ( P<0.001). The mean CTDIvol for the control scans were 1.88 ± 0.09 mGy and 13.16 ± 0.40 mGy for groups A and B, respectively ( P < 0.001). The success rate in group A was 91.2% and 87.9% in group B ( P = 0.56). No negative effect on image-quality parameters, time of FNAC, and number of control scans were found. Conclusion: We successfully developed a low-dose protocol for CT-guided MSK biopsies that maintains diagnostic accuracy and image quality at a fraction of the RD compared to the reference biopsy protocol at our clinic.

22 February 2025 in European Radiology Experimental
Verified
Journal Article
Open access
PDF file
ZAZlatan Alagic
Zlatan Alagic
CDCarlos Valls Duran
Carlos Valls Duran
ASAnders Svensson-Marcial
Anders Svensson-Marcial
SKSeppo K. Koskinen
Seppo K. Koskinen
Background: We evaluated the diagnostic capability of photon-counting detector computed tomography (PCD-CT) spectral variables in late arterial phase (LAP) and portal venous phase (PVP) to discriminate between local tumor recurrence (LTR) and postoperative changes (POC) after pancreatic ductal adenocarcinoma (PDAC) resection. Methods: Seventy-three consecutive PCD-CT scans in 73 patients with postoperative soft-tissue lesions (PSLs) were included, 42 with POC and 31 with LTR. Regions of interest were drawn in each PSL, and spectral variables were calculated: iodine concentration (IC), normalized IC (NIC), fat fraction, attenuation at 40, 70, and 90 keV, and slope of the spectral curve between 40–90 keV. Multivariable binary logistic regression models were constructed. Diagnostic performance was assessed for LAP and PVP using receiver operating characteristic analysis. Results: In LAP, all variables except fat fraction showed significant differences between LTR and POC (p ≤ 0.025). In PVP, all variables except NIC and fat fraction demonstrated significant differences between LTR and POC (p ≤ 0.005). Logistic regression analysis included NIC and 70 keV in the LAP-based model and IC and 90 keV in the PVP-based model. Both models achieved a higher area under the curve (AUC) than individual spectral variables in each phase. The LAP-based model achieved an AUC of 0.919 with 94% sensitivity, 84% specificity, and 87% accuracy, while the PVP-based model reached 0.820, 71%, 88%, and 81%, respectively. Conclusion: Spectral variables from PCD-CT help distinguish between LTR and POC in LAP and PVP post-PDAC resection. Multivariable logistic regression improves diagnostic performance, especially in LAP. Relevance statement: Measuring normalized iodine concentration and attenuation at 70 keV in late arterial phase, or iodine concentration and attenuation at 90 keV in portal venous phase, and incorporating these values into a logistic regression model can help differentiate between local tumor recurrence and postoperative changes after pancreatic ductal adenocarcinoma resection. Key Points: Distinguishing recurrence from postoperative changes on CT after pancreatic ductal adenocarcinoma resection is challenging. PCD-CT spectral variable values differed significantly between local tumor recurrence (LTR) and postoperative changes (POC). Logistic regression of spectral variables can help distinguish LTR from POC. The late arterial phase-based model reached an AUC of 0.919 with 94% sensitivity and 84% specificity. Graphical

26 September 2024 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
ZAZlatan Alagic
Zlatan Alagic
CDCarlos Valls Duran
Carlos Valls Duran
CSChikako Suzuki
Chikako Suzuki
KHKolbeinn Halldorsson
Kolbeinn Halldorsson
ASAnders Svensson-Marcial
Anders Svensson-Marcial
SKSeppo K. Koskinen
Seppo K. Koskinen
CT (EID-CT), which down-weights low-energy photons, PCD-CT counts photons equally across the entire X-ray energy spectrum, thereby increasing the iodine signal. Moreover, since the energy information of human organs primarily resides within the relatively low-energy X-ray spectrum, PCD-CT improves soft tissues contrast. Setting the low energy threshold slightly above electronic noise levels effectively minimizes noise. Additionally, PCD-CT's smaller detector pixel size, compared to EID-CT, enhances spatial resolution. Combined with improved iodine contrast, this can enhance the detectability of small objects [7, 8]. This may be particularly significant for detecting PDAC in the PVP, where the attenuation differences between pancreatic parenchyma and the tumor are less pronounced compared to the LAP [5]. Furthermore, PCD-CT obtains spectral information from every scan because the energy of each detected photon is registered and binned. This energy information can be utilized to generate virtual monoenergetic images (VMIs), and for material decomposition, such as generating material density iodine (MD-iodine) images [9].